Valuation Daiichi Sankyo Company, Limited

Equities

4568

JP3475350009

Pharmaceuticals

Delayed Japan Exchange Other stock markets 05:08:38 12/03/2026 GMT			5-day change	1st Jan Change
2,909.00 ^JPY	+1.91%		+2.25%	-13.14%

03-09	AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu	CI
03-09	UK Shares Start Week in Red as Oil Prices Surge Amid US-Iran War	MT

Company Valuation: Daiichi Sankyo Company, Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	6,179,276	5,136,821	9,244,546	9,159,669	6,590,893	5,274,129	-	-
Change	-	-16.87%	79.97%	-0.92%	-28.04%	-19.98%	-	-
Enterprise Value (EV) ¹	5,538,193	4,456,437	8,995,480	8,614,202	6,052,387	4,774,143	4,794,397	4,754,243
Change	-	-19.53%	101.85%	-4.24%	-29.74%	-21.12%	0.42%	-0.84%
P/E ratio	82.3x	76.7x	84.7x	45.6x	22.5x	17x	15.2x	13x
PBR	4.86x	3.8x	6.39x	5.43x	4.1x	2.85x	2.68x	2.36x
PEG	-	-7.1x	1.3x	0.5x	0.5x	2.15x	1.3x	0.8x
Capitalization / Revenue	6.42x	4.92x	7.23x	5.72x	3.49x	2.48x	2.26x	2.04x
EV / Revenue	5.75x	4.26x	7.04x	5.38x	3.21x	2.25x	2.06x	1.84x
EV / EBITDA	45.7x	33.9x	47.8x	31.8x	15.1x	11.1x	9.86x	8.97x
EV / EBIT	86.8x	61x	74.6x	40.7x	18.2x	13.4x	11.7x	9.9x
EV / FCF	36.2x	58.3x	-62.8x	27.2x	-97x	17.3x	22.5x	17.7x
FCF Yield	2.76%	1.72%	-1.59%	3.68%	-1.03%	5.78%	4.44%	5.63%
Dividend per Share ²	27	27	30	50	60	78.15	84.18	90.52
Rate of return	0.84%	1.01%	0.62%	1.05%	1.71%	2.74%	2.95%	3.17%
EPS ²	39.17	34.94	56.96	104.7	156	168.3	188.4	220.2
Distribution rate	68.9%	77.3%	52.7%	47.8%	38.5%	46.4%	44.7%	41.1%
Net sales ¹	962,516	1,044,900	1,278,478	1,601,700	1,886,256	2,125,410	2,332,203	2,588,793
EBITDA ¹	121,177	131,270	188,369	271,234	400,574	428,912	486,204	530,004
EBIT ¹	63,795	73,000	120,580	211,600	331,925	355,651	409,667	480,314
Net income ¹	75,958	67,000	109,188	200,700	295,756	310,870	347,495	403,431
Net Debt ¹	-641,083	-680,384	-249,066	-545,467	-538,506	-499,986	-479,732	-519,886
Reference price ²	3,225.00	2,680.00	4,822.00	4,777.00	3,511.00	2,854.50	2,854.50	2,854.50
Nbr of stocks (in thousands)	1,916,055	1,916,724	1,917,160	1,917,452	1,877,212	1,847,654	-	-
Announcement Date	27/04/21	27/04/22	27/04/23	25/04/24	25/04/25	-	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DAIICHI SANKYO COMPANY, LIMITED	16.98x	2.24x	11.14x	2.75%	33.35B
ELI LILLY AND COMPANY	29.43x	11.08x	22.26x	0.66%	895B
JOHNSON & JOHNSON	25.86x	6.02x	16.39x	2.17%	587B
ABBVIE INC.	24.65x	6.75x	13.55x	3.05%	401B
ROCHE HOLDING AG	18.04x	4.39x	10.87x	3%	345B
ASTRAZENECA PLC	24.8x	5.16x	14.3x	1.69%	306B
NOVARTIS AG	21.41x	5.76x	14.24x	2.81%	300B
MERCK & CO., INC.	27.37x	4.79x	14.99x	2.88%	289B
AMGEN INC.	25.26x	6.39x	11.37x	2.67%	202B
GILEAD SCIENCES, INC.	20.59x	6.26x	11.33x	2.19%	184B
Average	23.44x	5.89x	14.04x	2.39%	354.38B
Weighted average by Cap.	25.13x	7.02x	15.94x	2.08%